Related Experiment Videos
Enhancing the benefits of pharmaceuticals: what should states do?
Clinical Therapeutics
|July 7, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Decision-makers' use of pharmacoeconomics: what does the research tell us?
Expert review of pharmacoeconomics & outcomes research·2009
Use and costs of ambulatory care services among Medicare enrollees with schizophrenia.
Psychiatric services (Washington, D.C.)·2001
Lower body osteoarticular pain and dose of analgesic medications in older disabled women: the Women's Health and Aging Study.
American journal of public health·1999
The effect of managed care on prescription drug costs and benefits.
PharmacoEconomics·1999
Services to families of adults with schizophrenia: from treatment recommendations to dissemination.
Psychiatric services (Washington, D.C.)·1999
Issues in Monitoring Oncology Trials.
Clinical therapeutics·2026
Quantitative Systems Pharmacology (QSP): Bridging Biology and Mechanism with Clinical Drug Development Decisions.
Journal of clinical pharmacology·2026
Joint Learning of Drug-Drug Combination and Drug-Drug Interaction via Coupled Tensor-Tensor Factorization with Side Information.
Journal of computational biology : a journal of computational molecular cell biology·2026
[225Ac]Ac-iPSMA Radiopharmaceuticals for Targeted Alpha Therapy: Design, Synthesis, and Preclinical Evaluation.
International journal of molecular sciences·2026
Comparison of telmisartan with losartan, valsartan, and candesartan on the risk of new-onset diabetes mellitus.
Journal of human hypertension·2026
The Incretin Revolution: Integrating Incretin-Based Therapies into Clinical Care.
Biomedical journal·2026